MED-A-301

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMED-A-301
Drug Alias Nameactivin A receptor (Medexis)ALK4 receptor (Medexis)MED-A-301
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionActivin receptor-like kinase 4 modulators
TargetsActivin receptor-like kinase 4
Therapy Area/IndicationsMacular DegenerationDiabetic RetinopathyNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGreece
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Ioannina
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedexis Biotech SA
Active IndicationsN/A
Inactive IndicationsMacular DegenerationDiabetic RetinopathyNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A